Intralesional Injection of STS in Treatment of Calcinosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intralesional Injection of STS in Treatment of Calcinosis — Stella

Home/Systemic Sclerosis (SSc)/

View on ClinicalTrials.gov

Recruiting

Back to Systemic Sclerosis (SSc) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

UPMC Arthritis and Autoimmunity Center, Pittsburgh, Pennsylvania

Key details

Phase

Safety & dosing

Sponsor

Robyn T. Domsic, MD, MPH

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment target

~20 participants

Started

March 2025

Primary completion

August 2028

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.